APA (7th ed.) Citation

Shin, S. H., Ju, E. J., Park, J., Ko, E. J., Kwon, M. R., Lee, H. W., . . . Choi, E. K. (2023). ITC-6102RO, a novel B7-H3 antibody-drug conjugate, exhibits potent therapeutic effects against B7-H3 expressing solid tumors. Cancer Cell International, 23(1), 1. https://doi.org/10.1186/s12935-023-02991-x

Chicago Style (17th ed.) Citation

Shin, Seol Hwa, et al. "ITC-6102RO, a Novel B7-H3 Antibody-drug Conjugate, Exhibits Potent Therapeutic Effects Against B7-H3 Expressing Solid Tumors." Cancer Cell International 23, no. 1 (2023): 1. https://doi.org/10.1186/s12935-023-02991-x.

MLA (9th ed.) Citation

Shin, Seol Hwa, et al. "ITC-6102RO, a Novel B7-H3 Antibody-drug Conjugate, Exhibits Potent Therapeutic Effects Against B7-H3 Expressing Solid Tumors." Cancer Cell International, vol. 23, no. 1, 2023, p. 1, https://doi.org/10.1186/s12935-023-02991-x.